67614-33-9

Basic information

• Product Name: S 5602B-beta
• CAS NO: 67614-33-9
• Molecular Formula: C₂₅H₂₂ClNO₃
• Molecular Weight: 419.908
• Mol File: 67614-33-9.mol
• Article Data: 2

Chemical Properties

• Density: 1.21
• CAS DataBase Reference: S 5602B-beta(CAS DataBase Reference)
• NIST Chemistry Reference: S 5602B-beta(67614-33-9)
• EPA Substance Registry System: S 5602B-beta(67614-33-9)

Safety Data

• Hazardous Substances Data: 67614-33-9(Hazardous Substances Data)

Usage

General Description

S 5602B-beta is a chemical compound with the molecular formula C21H33NO. It is a beta-adrenergic receptor agonist, meaning it activates the beta-adrenergic receptors in the body. This chemical is commonly used in the pharmaceutical industry as a bronchodilator to treat conditions such as asthma and chronic obstructive pulmonary disease (COPD). S 5602B-beta works by relaxing the muscles in the airways, allowing for easier breathing and improved airflow to the lungs. It is an important medication for managing respiratory conditions and has been proven effective in providing relief for patients with bronchospasm.

Upstream product

• 39515-51-0 3-Phenoxybenzaldehyde 
• 63640-09-5 (R)-2-(4-chlorophenyl)-3-methylbutyric acid 
• 2012-74-0 2-(4-chlorophenyl)-3-methylbutyric acid 
• 39515-47-4 2-hydroxy-2-(3-phenoxyphenyl)acetonitrile 
• 71697-10-4 (R)-4-chloro-α-(1-methylethyl)benzenecaetyl chloride 

Relevant articles and documents

Development of an immunoassay for the pyrethroid insecticide esfenvalerate

A competitive enzyme-linked immunosorbent assay was developed for the detection of the pyrethroid insecticide esfenvalerate. Two haptens containing amine or propanoic acid groups on the terminal aromatic ring of the fenvalerate molecule were synthesized and coupled to carrier proteins as immunogens. Five antisera were produced and screened against eight different coating antigens. The assay that had the least interference and was the most sensitive for esfenvalerate was optimized and characterized. The I50 for esfenvalerate was 30 ± 6.2 μg/L, and the lower detection limit (LDL) was 3.0 2+ 1.8 μg/L. The assay was very selective. Other pyrethroid analogues and esfenvalerate metabolites tested did not cross-react significantly in this assay. To increase the sensitivity of the overall method, a C18 sorbent-based solid-phase extraction (SPE) was used for water matrix. With this SPE step, the LDL of the overall method for esfenvalerate was 0.1 μg/L in water samples.